Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBT vs FBIOX
Shared holdings
16
FBT covered by FBIOX
24.13%
FBIOX covered by FBT
24.13%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
FBIOX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| ABBVIE INC | 12.90% | |
| KRYSTAL BIOTECH INC | 9.08% | |
| GILEAD SCIENCES INC | 8.55% | |
| AMGEN INC | 8.13% | |
| ALNYLAM PHARMACEUTICALS INC | 3.01% | |
| Fidelity Securities Lending Cash Central Fund | 2.48% | |
| PRAXIS PRECISION MEDICINES INC | 2.40% | |
| Ascendis Pharma A/S | 2.38% | |
| INSMED INC | 2.21% | |
| UCB SA | 2.12% | |
| ARGENX SE SPONSORED ADR | 2.09% | |
| REGENERON PHARMACEUTICALS INC | 1.44% | |
| MODERNA INC | 1.40% | |
| SCHOLAR ROCK HOLDING CORP | 1.33% | |
| NATERA INC | 1.26% | |
| COGENT BIOSCIENCES INC | 1.20% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.07% | |
| BIOGEN INC | 1.05% | |
| ROIVANT SCIENCES LTD | 1.04% | |
| VERTEX PHARMACEUTICALS INC | 1.02% | |
| BRIDGEBIO PHARMA INC | 0.86% | |
| PROTAGONIST THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.83% | |
| REVOLUTION MEDICINES INC | 0.82% | |
| KYMERA THERAPEUTICS INC | 0.77% | |
| IONIS PHARMACEUTICALS INC | 0.70% | |
| ARRIVENT BIOPHARMA INC | 0.70% | |
| CRINETICS PHARMACEUTICALS INC | 0.69% | |
| Abivax SA SPONSORED ADS | 0.67% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.65% | |
| DISC MEDICINE INC | 0.65% | |
| GALDERMA GROUP A | 0.64% | |
| ZEALAND PHARMA A | 0.62% | |
| CYTOKINETICS INC | 0.57% | |
| CANDEL THERAPEUTICS INC | 0.57% | |
| BIO AB2 HOLDINGS LLC ARC | 0.54% | |
| VIRIDIAN THERAPEUTICS INC | 0.54% | |
| VAXCYTE INC | 0.53% | |
| STOKE THERAPEUTICS INC | 0.53% | |
| NUVALENT INC-A | 0.51% | |
| APOGEE THERAPEUTICS INC | 0.50% | |
| TREVI THERAPEUTICS INC | 0.50% | |
| ANNEXON INC | 0.48% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.47% | |
| DIANTHUS THERAPEUTICS INC | 0.43% | |
| VOR BIOPHARMA INC | 0.43% | |
| EDGEWISE THERAPEUTICS INC | 0.43% | |
| UNITED THERAPEUTICS CORP DEL | 0.41% | |
| INTELLIA THERAPEUTICS INC | 0.40% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.